Keyword

Contrave

Description: Contrave is a brand-name combination medication containing naltrexone and bupropion, used for chronic weight management in adults with obesity.
Wikidata ID: wiki/Q4998036
OpenAlex ID: keywords/contrave
2014 · Assumpta Caixas, Lara Albert, et al. · Drug Design Development and Therapy · 248
2010 · Pradeep J. Nathan, Barry V. O’Neill, et al. · CNS Neuroscience & Therapeutics · 126
2010 · G.A. Kennett, P.G. Clifton · Pharmacology Biochemistry and Behavior · 82
2012 · David J. Heal, Jane Gosden, et al. · Neuropharmacology · 70
2015 · Sarah L. Greig, Gillian M. Keating · Drugs · 64
2010 · Albert Stuart Reece · Medical Hypotheses · 44
2019 · Yan Zhou, Francesco Leri, et al. · Pharmacology Biochemistry and Behavior · 24
2017 · Priyanka A. Singh, Kerry P. Cassel, et al. · Journal of Emergency Medicine · 22
2011 · Susan L. Mercer · ACS Chemical Neuroscience · 18
2015 · Yusuke Hada, Toshimasa Yamauchi, et al. · Nihon Naika Gakkai Zasshi · 14
2010 · In March 2010, Orexigen submitted an NDA for approval of naltrexone SR/bupropion SR (Contrave®) for the treatment of obesity in the US. The new drug application (NDA) comprises data from the Contrave Obesity Research (COR) clinical program in more than 4500 patients.[ · Drugs in R&D · 12
2014 · Dragana Nikolic, Peter P Toth, et al. · Clinical Lipidology · 10
2009 · Derek Hausenloy · Clinical Lipidology · 8
2017 · Vishnu D. Sharma, François P. Combes, et al. · The Journal of Clinical Pharmacology · 6
Works count: 83
Citation count: 2,285
Year
Topic
Type